record

ENSO Recovery - Augusta

Augusta, ME

Medication used in treatmentDirectory coverage. Read the methodology and limitations.

Facility contact

Care types: Substance use treatment, Transitional housing, halfway house, or sober home Source
Care settings: Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment Source
OUD medication support: Medication used in treatment Source
Opioid medications: Buprenorphine used in Treatment, Naltrexone used in Treatment Source
Opioid treatment responses: Buprenorphine maintenance, Prescribes buprenorphine, Prescribes naltrexone, Relapse prevention with naltrexone Source
Other pharmacotherapies: Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Nicotine replacement, Non-nicotine smoking/tobacco cessation Source
Treatment approaches: Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy, 12-step facilitation Source

Payment methods: Federal, or any government funding for substance use treatment programs, Medicaid, Cash or self-payment, SAMHSA funding/block grants Source
Telehealth reported: Yes Source
Transportation assistance: No Source
Ancillary services: Case management service Source

Age groups: Young Adults, Adults, Seniors Source
Co-occurring treatment reported: No Source
All oversight and accreditation responses: State substance use treatment agency, State mental health department Source
Facility operation: Private for-profit organization Source
Directory field completeness: 100 / 100 Source

Research workflow

Unlock shortlist comparison, local notes, export, and complete directory context.